Viveon Health increases consideration offered to Clearday shareholders

Clearday announced an amendment to the Definitive Merger Agreement previously signed on April 5, 2023, issued by Viveon Healthcare Acquisition Corporation. Viveon confirmed its commitment to the merger and increased Clearday’s valuation. Viveon and Clearday continue to work to close the merger. The terms of our business combination improved steadily as Clearday’s true potential was understood by the Viveon team. An initial letter of intent in March 2023 valued the Company at $150 million. The formal definitive agreement In April increased the consideration to $250 million. Further collaboration and analysis have led the Viveon Board to approve an amendment to the definitive agreement on August 28, 2023. The amended agreement increases again the offer to Clearday shareholders to $500 million. The two companies will now move prudently toward regulatory and shareholder approval of the combination.